Trastuzumab emtansine in the treatment of HER-2-positive metastatic breast cancer patients

By Bighin Claudia   Pronzato Paolo   Del Mastro Lucia  

Future Oncology, Vol. 9, Iss. 7, 2013-07 ,pp. : 955-957

Future Medicine

Access to resources Recommend Favorite

Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the antitumor effects of trastuzumab emtansine

By                    

Oncology Reports, Vol. 34, Iss. 1, 2015-01 ,pp. : 504-510

Spandidos Publications

Access to resources Recommend Favorite

Trastuzumab combined with chemotherapy for the treatment of HER2-positive metastatic breast cancer: Pivotal trial data

By Eiermann W.  

Annals of Oncology, Vol. 12, Iss. 12, 2001-12 ,pp. : 57-62

Springer Publishing Company

Access to resources Recommend Favorite

Implementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in the Netherlands

By Munck L.   Schaapveld M.   Siesling S.   Wesseling J.   Voogd A.   Tjan-Heijnen V.   Otter R.   Willemse P.  

Breast Cancer Research and Treatment, Vol. 129, Iss. 1, 2011-08 ,pp. : 229-233

Springer Publishing Company

Access to resources Recommend Favorite

A Phase II Trial of Vinflunine As Monotherapy or in Combination with Trastuzumab as First-Line Treatment of Metastatic Breast Cancer

By Yardley Denise A.   McCleod Michael   Schreiber Fred   Murphy Patrick   Patton Jeffrey   Thompson Dana S.   Shastry Mythili   Rubin Mark   Melnik Marianne   Burris Howard A.   Hainsworth John D.  

Cancer Investigation, Vol. 28, Iss. 9, 2010-10 ,pp. : 925-931

Informa Healthcare

Access to resources Recommend Favorite